In hereditary cases, we observe shorter telomeres in cancer-affected MMR gene mutation carriers than in cancer-free carriers, suggesting either that the shortened telomeres are a result of the disease, or that shorter telomere length is an additional risk factor for LS patients, i.e. a risk modifier. This evidence concerns the gene MRC1 and cancer.